"0074-2625-28" National Drug Code (NDC)

Mavyret 4 CARTON in 1 CARTON (0074-2625-28) / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK
(AbbVie Inc.)

NDC Code0074-2625-28
Package Description4 CARTON in 1 CARTON (0074-2625-28) / 7 DOSE PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 DOSE PACK
Product NDC0074-2625
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameMavyret
Non-Proprietary NameGlecaprevir And Pibrentasvir
Dosage FormTABLET, FILM COATED
UsageORAL
Start Marketing Date20170803
Marketing Category NameNDA
Application NumberNDA209394
ManufacturerAbbVie Inc.
Substance NameGLECAPREVIR; PIBRENTASVIR
Strength100; 40
Strength Unitmg/1; mg/1
Pharmacy ClassesBreast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor [EPC], Hepatitis C Virus NS5A Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA], UGT1A1 Inhibitors [MoA]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/0074-2625-28